Skip to content
healthcare.dev

Yargesa

NDC 42799-709, Miglustat, capsule, from Edenbridge Pharmaceuticals LLC..

Product NDC
42799-709
Status
Listed
Labeler
Edenbridge Pharmaceuticals LLC.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209821
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42799-709 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIGLUSTAT100 mg/1

Pharmacologic classes

Enzyme Stabilizer [EPC]; Enzyme Stabilizers [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]

Package NDCNDC-11Package
42799-709-15427990709151 BLISTER PACK in 1 CARTON (42799-709-15) / 15 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2b371dfe-e2b0-47fe-b677-a7bde7149f87

Use it

Look up 42799-709 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42799-709 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42799-709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.